The CNRS at Vivatech 2024

11h – 11h45 :
Generative AI and innovation: an always winning combination?
Generative AI, a concrete innovation that is pervasive in our society, is causing radical changes in uses and occupations. A concrete illustration of basic research, the Jean Zay supercomputer has garnered wide attention, and is helping to develop generative AI. But does one innovate more and better with AI?

Speakers :

• Adeline Nazarenko, Director of CNRS Sciences informatiques
• Christophe Cerisara, CNRS researcher

14h – 14h45 :
Profits and societal impact: what technology transfer model for free software?
Academic research produces numerous software programs whose dissemination could prove beneficial well beyond the walls of laboratories. Free software? Open source? Numerous technology transfer strategies are possible, but they diverge from the usual patterns.

Speakers :

• Isabelle Blanc (MESR), Chief data and software officer
• Alexandre Zapolsky, Chairman of Linagora
• Pierre-Henri Wuillemin, Teacher-researcher in artificial intelligence and data science at LIP6 - Computer Science Laboratory (CNRS/Sorbonne University)
• Mehdi Gmar, Director CNRS Innovation

15h30 – 16h15 :
High-risk research and groundbreaking innovation: when basic research creates disruption
The CNRS conducts basic research, and is thus positioned very far upstream in the innovation chain. Its research staff works on subjects that will surpass our current knowledge and revolutionise the society of the future. An insight with speakers who are shaping the world… of tomorrow.

Speakers :

• Stéphane Lemaire, CNRS Director of Research, Co-founder of Biomemory
• Guido Masella, CTO & Co-founder of QPerfect
• Thomas Ebbesen, Director of l'USIAS (Institut d'Études Avancées de l'Université de Strasbourg)

17h – 17h45 :
Public research, a breeding ground for health innovation in the field of therapy
France is Europe’s 3rd most innovative country in the fight against cancer (2024 EPO study). Over the last decade, the rising number of patent applications submitted by French applicants was partially due to developments in immunotherapy and targeted therapy. An overview.

Speakers :

• Martine Caroff, CSO and Co-founder of Hephaïstos Pharma
• Michel Khrestchatisky, CNRS Research Director, Institute of Neurophysiopathology / Co-Founder and Scientific Advisor of Vect-Horus
• Franck Lethimonnier, Director of Inserm's Health Technologies Institute, co-pilot of PEPR Biotherapies and Bioproduction of Innovative Therapies

14h – 14h45 :
From the laboratory to the factory: the challenges of scaling up?
How can the challenges of scaling up be overcome? Funding, expertise, real estate issues… What are the levers and obstacles faced by deeptech start-ups in transitioning from the laboratory to the factory?

Speakers :

• Arnaud Villers d’Arbouet, Founding Partner et CEO de Mecaware
• Yun Luo, Chairman of ROSI
• Vincent Lamande, Chairman of Ouest Valorisation

15h30 – 16h15 :
Derisking technology: taking stock of 10 years of CNRS support for deeptech projects
The CNRS is celebrating the 10th anniversary of its prematuration programme, which provides funding and support for emerging projects with high innovation potential in their early stages of technological development. This is essential for derisking innovation projects emerging from public research.

Speakers :

• Cyrille Deranlot, Chairman of Daumet
• Thomas Hiriart, Chairman and CEO of Ion-X

17h – 17h45 :
The European Union: boosting innovation emerging from public research?
How does the European Union sustain a dynamic that fosters innovation growing out of public research? Feedback from entrepreneurs who have benefited from European Union funding.

Speakers :

• Alain Mermet, Director, Europe and International Division
• Sylvie Lorente, Associate Dean for Research and Innovation College of Engineering Villanova University, Pennsylvania, USA / Professeur INSA Toulouse
• Amanda Silva Brun, CNRS Director of Research, Co-founder of Everzom.
• Dafiné Ravelosona, CNRS Director of Research, Co-founder of Spin-Ion Technologies

14h – 14h45 :
Public research in the service of innovation in defence and security
Public research is a tremendous breeding ground for meeting our country’s defence and security needs. AI, cybersecurity, quantum technology, health… An overview of innovation that grew out of public research with CNRS partners.

Speakers :

• Romain Lucken, Chairman, Co-founder of Aldoria
• Christophe Gacquière, Managing Director and Co-Founder of MC2
• Alain Foucaran, Professor, Deputy Scientific Director at CNRS Ingénierie and Scientific Coordinator of the Agence Innovation Défense / CNRS framework agreement 

15h30 – 16h15 :
What indicators for reconciling innovation and societal impact?
While the chief indicator on the market remains economic profitability, how can innovation with a social, societal, or environmental impact be supported, encouraged, and assessed? The CNRS is actively involved in this issue, and is launching the first call for proposals dedicated to societal innovation.

Speakers :

• Jean-Luc Moullet, Executive Vice-President, Innovation
• Aziz Moqrich, CNRS Research Director and CSO of Tafalgie therapeutics
• Olivier Palluault, Managing Director of the Scop Ellyx

17h – 17h45 :
Research and innovation in the service of the environmental transition
The French government entrusted the CNRS with managing the Climate, Biodiversity, and Sustainable Societies programme agency.  In keeping with the organisation’s commitments in the service of society, many enterprises that emerged from laboratories under its supervisory authority pursue activity connected to the environmental transition. How can this dynamic be supported?

Speakers :

• Thomas Beaulaton, Business Developer Naïo Technologies
• Frédéric Prochazk, Co-Founder and Scientific Director of Lactips
• Eric Marty, Managing Partner Demeter
• Elsa Cortijo, Executive Director of the "Climate, Biodiversity and Sustainable Societies" Program Agency